Teva Pharmaceuticals' RISE Challenge

Venture Capital Active Israel
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$40.0M
total disclosed, rounds participated
Stages
—

Portfolio · 2

Keheala
Healthcare Infrastructure and Behavioral Expertise
1 round $5K committed Latest: 2018-01
VBL Therapeutics
Targeted Therapies for Immune-inflammatory Diseases
1 round $40.0M committed Latest: 2010-10

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Teva Pharmaceuticals' RISE Challenge's primary investment focus?
Teva Pharmaceuticals' RISE Challenge primarily focuses on the Health Tech & Life Sciences sector, with all its recorded investments and exits falling within this area.
Can you name a notable portfolio company for Teva Pharmaceuticals' RISE Challenge?
A notable portfolio company for Teva Pharmaceuticals' RISE Challenge is VBL Therapeutics, which operates in the B2B business model and focuses on targeted therapies for immune-inflammatory diseases.
Has Teva Pharmaceuticals' RISE Challenge had any exits?
Yes, Teva Pharmaceuticals' RISE Challenge had an exit in October 2014 when VBL Therapeutics went public on NASDAQ with a valuation of $120M, having raised $40M in capital.
When was Teva Pharmaceuticals' RISE Challenge founded?
Teva Pharmaceuticals' RISE Challenge was created in May 2019.
What is the geographic focus of Teva Pharmaceuticals' RISE Challenge?
Teva Pharmaceuticals' RISE Challenge is headquartered in Israel.